Profil
Ali Hariri is currently the Chief Medical Officer at Eloxx Pharmaceuticals, Inc. Prior to this, he worked as the Senior Head-Global Project at Genzyme Corp.
from 2016 to 2021.
He completed his undergraduate degree at The California State University and his doctorate at UC San Diego School of Medicine.
Postes actifs de Ali Hariri
| Sociétés | Poste | Début |
|---|---|---|
| ELOXX PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 08/09/2021 |
Anciens postes connus de Ali Hariri
| Sociétés | Poste | Fin |
|---|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | 01/08/2021 |
Formation de Ali Hariri
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
The California State University
The California State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UC San Diego School of Medicine
UC San Diego School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eloxx Pharmaceuticals, Inc.
Eloxx Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that discovers and develops therapeutics to treat cystic fibrosis, inherited retinal disorders and other diseases | Health Technology |
















